Diamines & Chemicals Files SEBI Disclosure Following Warrant Conversion

2 min read     Updated on 27 Mar 2026, 03:48 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Diamines & Chemicals Limited has filed a comprehensive SEBI disclosure under Regulation 29(2) following the conversion of 2,69,402 warrants into equity shares by the promoter group on March 24, 2026. The conversion increased the promoter group's shareholding from 55.98% to 57.10%, with seven promoter entities participating in the conversion led by Amit M. Mehta and Cherry A. Mehta. The company's paid-up capital increased from Rs. 9,78,39,900 to Rs. 10,05,33,920, while 3,23,388 warrants remain outstanding for future conversion.

powered bylight_fuzz_icon
35903564

*this image is generated using AI for illustrative purposes only.

Diamines & Chemicals Limited has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, following the successful conversion of 2,69,402 warrants into equity shares. The conversion was executed on March 24, 2026, after receiving board approval and the balance subscription amount from allottees.

SEBI Disclosure Requirements

The company received the disclosure dated March 25, 2026, from promoter group member Amit M. Mehta on behalf of the promoter and promoter group. The filing was necessitated due to the substantial acquisition of shares through warrant conversion, which increased the promoter group's shareholding from 55.98% to 57.10%.

Parameter: Details
Filing Date: March 25, 2026
Regulation: SEBI Takeover Regulations 29(2)
Mode of Acquisition: Conversion of warrants into equity shares
Acquirer and PAC: 7 promoter entities + 3 PAC members

Warrant Conversion Details

The conversion involved 2,69,402 warrants at Rs. 414.00 per warrant, representing 75% of the issue price of Rs. 552.00. The company received Rs. 11,15,32,428.00 from allottees for the conversion, which stems from the original allotment of 9,06,390 warrants issued on October 01, 2024.

Metric: Before Conversion After Conversion
Paid-up Capital: Rs. 9,78,39,900 Rs. 10,05,33,920
Number of Shares: 97,83,990 1,00,53,392
Diluted Share Capital: Rs. 10,69,03,800 1,06,90,380 shares
Face Value per Share: Rs. 10.00 Rs. 10.00

Promoter Group Shareholding Changes

The warrant conversion resulted in significant changes to the promoter group's shareholding pattern. Seven promoter entities participated in the conversion, with Amit M. Mehta and Cherry A. Mehta being the largest converters.

Promoter Entity: Shares Converted Post-Conversion Holding Shareholding %
Amit M. Mehta: 71,460 13,59,459 13.52%
Cherry A. Mehta: 67,582 11,50,829 11.45%
Perfo Chem India Pvt Ltd: 16,196 9,87,195 9.82%
Harsh A. Mehta: 36,816 5,53,834 5.51%
Mohak A. Mehta: 40,546 5,49,024 5.46%
Finorga (India) Pvt Ltd: 12,752 5,16,320 5.14%
S. Amit Specialty Chemicals Pvt Ltd: 18,250 5,13,714 5.11%

Outstanding Warrants and Future Conversions

Following this conversion, 3,23,388 warrants remain outstanding with the promoter group, representing 3.03% of the diluted share capital. The remaining warrants can be converted within 18 months from the original allotment date of October 01, 2024, upon payment of the balance 75% warrant amount. Additionally, 6,36,988 total warrants remain pending for conversion across all allottees.

The newly allotted equity shares will rank pari passu with existing equity shares, subject to completion of necessary corporate actions and receipt of listing and trading approvals from BSE and NSE.

Will the remaining 3,23,388 outstanding warrants held by the promoter group be converted before the April 2026 deadline, potentially increasing their shareholding beyond 60%?

How might the increased promoter shareholding from 55.98% to 57.10% affect the company's ability to raise funds from institutional investors or impact its public float requirements?

What strategic initiatives or expansion plans does Diamines & Chemicals have in mind that would justify the Rs. 11.15 crore capital infusion from warrant conversions?

Diamines and Chemicals Limited Board Meeting Scheduled for March 24, 2026 to Consider Warrant Conversion

1 min read     Updated on 17 Mar 2026, 04:19 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Diamines and Chemicals Limited has scheduled a board meeting for March 24, 2026, to consider the conversion of warrants into equity shares on a preferential basis. The meeting is being held in compliance with SEBI (LODR) Regulations 2015, with formal notifications sent to BSE and NSE on March 17, 2026. The conversion will follow the original terms of warrant issuance and accommodate warrant holders' exercise of options.

powered bylight_fuzz_icon
35290194

*this image is generated using AI for illustrative purposes only.

Diamines & Chemicals Limited has announced that its board of directors will convene on March 24, 2026, to deliberate on the conversion of warrants into equity shares. The meeting has been scheduled in compliance with regulatory requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.

Meeting Details and Purpose

The board meeting is specifically convened to consider and approve the conversion of warrants into equity shares of the company. This conversion will be executed according to the terms established during the initial warrant issuance and will accommodate the exercise of options by warrant holders on a preferential basis.

Meeting Parameter: Details
Date: Tuesday, March 24, 2026
Primary Agenda: Conversion of Warrants into Equity Shares
Basis: Preferential allocation to warrant holders
Regulatory Framework: SEBI (LODR) Regulations 2015

Regulatory Compliance

The company has formally communicated this development to both major stock exchanges where its shares are listed. The notification was sent to BSE Limited and National Stock Exchange of India Limited on March 17, 2026, ensuring full compliance with Regulation 29 and Chapter IV of the SEBI (LODR) Regulations 2015.

Corporate Communication

The official notice was signed by Hemaxi Pawar, Company Secretary (Membership No.: A52581), and digitally authenticated on March 17, 2026. The communication emphasizes the company's commitment to maintaining transparency with regulatory authorities and stakeholders regarding significant corporate actions.

The board meeting may also address other business matters as deemed necessary by the directors, though the primary focus remains on the warrant conversion process.

More News on Diamines & Chemicals